Cathy Spillane

987 total citations
20 papers, 560 citations indexed

About

Cathy Spillane is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Cathy Spillane has authored 20 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Cathy Spillane's work include Cancer-related molecular mechanisms research (6 papers), Cancer Cells and Metastasis (5 papers) and MicroRNA in disease regulation (4 papers). Cathy Spillane is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Cancer Cells and Metastasis (5 papers) and MicroRNA in disease regulation (4 papers). Cathy Spillane collaborates with scholars based in Ireland, Australia and United Kingdom. Cathy Spillane's co-authors include John O’Leary, Orla Sheils, Cara Martin, Sharon O’Toole, Helen Keegan, Peter Koltay, Roland Zengerle, Gordon Blackshields, Michael Gallagher and Dermot Kenny and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Cathy Spillane

19 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathy Spillane Ireland	12	249	181	160	108	61	20	560
F Piccotti Italy	12	213 0.9×	126 0.7×	121 0.8×	84 0.8×	21 0.3×	23	408
Ayelet Zlotogorski‐Hurvitz Israel	10	434 1.7×	250 1.4×	77 0.5×	81 0.8×	31 0.5×	23	615
Yoomi Lee United States	12	323 1.3×	90 0.5×	221 1.4×	35 0.3×	101 1.7×	13	821
Youliang Weng China	12	213 0.9×	130 0.7×	84 0.5×	96 0.9×	60 1.0×	34	441
Kishan A.T. Naipal Netherlands	8	290 1.2×	89 0.5×	338 2.1×	126 1.2×	43 0.7×	12	546
Berina Eppink Netherlands	8	517 2.1×	89 0.5×	182 1.1×	202 1.9×	17 0.3×	12	776
Rosemarie ten Cate Netherlands	16	330 1.3×	107 0.6×	178 1.1×	196 1.8×	17 0.3×	25	659
Valérie Rouffiac France	16	302 1.2×	182 1.0×	190 1.2×	189 1.8×	38 0.6×	31	694
Chi-Ping Day United States	6	243 1.0×	110 0.6×	253 1.6×	135 1.3×	88 1.4×	6	582

Countries citing papers authored by Cathy Spillane

Since Specialization

Citations

This map shows the geographic impact of Cathy Spillane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Spillane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Spillane more than expected).

Fields of papers citing papers by Cathy Spillane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Spillane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Spillane. The network helps show where Cathy Spillane may publish in the future.

Co-authorship network of co-authors of Cathy Spillane

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Spillane. A scholar is included among the top collaborators of Cathy Spillane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Spillane. Cathy Spillane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Jay M., Jean-Louis Pujol, Jun Zhang, et al.. (2025). CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC. JTO Clinical and Research Reports. 6(8). 100859–100859.

Mohamed, Bashir M., Mark P. Ward, Mark Bates, et al.. (2023). Ex vivo expansion of circulating tumour cells (CTCs). Scientific Reports. 13(1). 3704–3704. 10 indexed citations

Spillane, Cathy, et al.. (2022). The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival. Human Cell. 35(5). 1547–1559. 3 indexed citations

O’Toole, Sharon, Cathy Spillane, Yanmei Huang, et al.. (2020). Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 181(3). 571–580. 8 indexed citations

Bates, Mark, Cathy Spillane, Michael Gallagher, et al.. (2020). The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer. PLoS ONE. 15(12). e0243715–e0243715. 11 indexed citations

Spillane, Cathy, et al.. (2019). Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade. PLoS ONE. 14(3). e0211538–e0211538. 63 indexed citations

Bates, Mark, Fiona Furlong, Michael Gallagher, et al.. (2019). Too MAD or not MAD enough: The duplicitous role of the spindle assembly checkpoint protein MAD2 in cancer. Cancer Letters. 469. 11–21. 22 indexed citations

Ffrench, Brendan, Claudia Gasch, Karsten Hokamp, et al.. (2017). CD10−/ALDH− cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy. Cell Death and Disease. 8(10). e3128–e3128. 14 indexed citations

Aherne, Sinéad, Paul Smyth, Michael Freeley, et al.. (2016). Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression. International Journal of Molecular Medicine. 38(2). 433–445. 12 indexed citations

10.

Gallagher, Michael, Cathy Spillane, Brendan Ffrench, et al.. (2015). Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones. Journal of Clinical Pathology. 68(9). 692–702. 4 indexed citations

11.

O’Toole, Sharon, Cathy Spillane, Cara Martin, et al.. (2015). Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer. BMC Cancer. 15(1). 547–547. 40 indexed citations

12.

Spillane, Cathy, et al.. (2015). Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion. BMC Cancer. 15(1). 627–627. 62 indexed citations

13.

Johnson, I. R., Emma J. Parkinson-Lawrence, Helen Keegan, et al.. (2015). Endosomal gene expression: a new indicator for prostate cancer patient prognosis?. Oncotarget. 6(35). 37919–37929. 34 indexed citations

14.

Vencken, Sebastian, Praveen Sethupathy, Gordon Blackshields, et al.. (2014). An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines. BMC Genomics. 15(1). 711–711. 15 indexed citations

15.

Norris, Lucy, Feras Abu Saadeh, Gordon Blackshields, et al.. (2014). A novel serum microRNA panel to discriminate benign from malignant ovarian disease. Cancer Letters. 356(2). 628–636. 72 indexed citations

16.

Spillane, Cathy, Karl Egan, Sharon O’Toole, et al.. (2014). Abstract 4951: Platelet cloaking of CTCs is a universal phenomenon, which drives metastasis. Cancer Research. 74(19_Supplement). 4951–4951. 1 indexed citations

17.

Gallagher, Michael, Cynthia Heffron, Alexandros Laios, et al.. (2012). Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples. Journal of Ovarian Research. 5(1). 2–2. 10 indexed citations

18.

Hayes, Brian, et al.. (2011). MYBL2 (B-MYB) in Cervical Cancer: Putative Biomarker. International Journal of Gynecological Cancer. 21(2). 206–212. 14 indexed citations

19.

Keegan, Helen, Cathy Spillane, Orla Sheils, et al.. (2011). Inkjet-like printing of single-cells. Lab on a Chip. 11(14). 2447–2447. 117 indexed citations

20.

Malkin, Alison, Aidan D. Meade, John O’Leary, et al.. (2010). Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy. The Analyst. 135(12). 3087–3087. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact